Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)

Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)

Bibliographic Details
Main Authors: Frey, Reiner, Mück, Wolfgang, Kirschbaum, Nina, Krätzschmar, Jörn, Weimann, Gerrit, Wensing, Georg
Format: Online
Language:English
Published: BioMed Central 2009
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313325/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313325/

Similar Items